1273 Effect of systemic immunosuppression timing on overall survival among immune checkpoint inhibitor recipients

1273 Effect of systemic immunosuppression timing on overall survival among immune checkpoint inhibitor recipients

Bibliographic Details
Main Authors:	Kun-Hsing Yu, Shijia Zhang, Nga Nguyen, Feng Liu, Nikolai Klebanov, Alexander Gusev, Shawn Kwatra, Yevgeniy R Semenov, Genevieve M Boland, Nicole R LeBoeuf, Kimberly Tang, Guihong Wan, Boshen Yan, Munachimso Amadife, Bonnie W Leung
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

1251 Seasonal and geographic patterns in cutaneous immune-related adverse events after treatment with immune checkpoint inhibitors: a multicenter analysis
by: Kerry Reynolds, et al.
Published: (2023-11-01)

1241 Clusters of multi-organ toxicities are associated with improved survival among immune checkpoint inhibitor recipients: a population-level study
by: Kun-Hsing Yu, et al.
Published: (2023-11-01)

Food and drug administration approval process for dermatology drugs in the United States
by: Emily Boozalis, et al.
Published: (2018-08-01)

Prediction of early-stage melanoma recurrence using clinical and histopathologic features
by: Guihong Wan, et al.
Published: (2022-10-01)

554 Clinical outcomes of patients treated with immune checkpoint inhibitor therapy for early-stage melanoma recurrence: a retrospective cohort study
by: Nga Nguyen, et al.
Published: (2023-11-01)

Differences in Responses of Immunosuppressed Kidney Transplant Patients to Moderna mRNA-1273 versus Pfizer-BioNTech
by: Dulat Bekbolsynov, et al.
Published: (2024-01-01)

826 Risk of COVID-19 infection among patients receiving immune checkpoint inhibitor therapy: a tertiary care hospital system collaboration with the Massachusetts department of health
by: Vartan Pahalyants, et al.
Published: (2020-11-01)

Racial disparities in the management of acne: evidence from the National Ambulatory Medical Care Survey, 2005–2014
by: Andrew T. Rogers, et al.
Published: (2018-04-01)

Identification of cutaneous immune-related adverse events by International Classification of Diseases codes and medication administration
by: Wenxin Chen, BS, et al.
Published: (2022-12-01)

The impact of stage-related features in melanoma recurrence prediction: A machine learning approach
by: Guihong Wan, PhD, et al.
Published: (2023-03-01)

Immune dynamics in SARS-CoV-2 experienced immunosuppressed rheumatoid arthritis or multiple sclerosis patients vaccinated with mRNA-1273
by: Niels JM Verstegen, et al.
Published: (2022-07-01)

MEVLÂNA CELÂLEDDİN RÛMÎ (1207-1273)
by: Sâfi Arpaguş
Published: (2007-12-01)

855 Cutaneous adverse events of immune checkpoint inhibitor therapy: incidence and types of reactive dermatoses
by: Shannon Wongvibulsin, et al.
Published: (2020-11-01)

Behaviour of a loose silty sand under static and cyclic loading conditions
by: LeBoeuf Denis
Published: (2019-01-01)

Cutaneous adverse events of immune checkpoint inhibitor therapy: incidence and types of reactive dermatoses
by: Thomas K. Le, et al.
Published: (2022-04-01)

HOW TO WIN A Lot More Business in a Lot Less Time : THE 10 COMMANDMENTS OF SPEED /
by: LeBoeuf, Michael, author
Published: (1993)

How to motivate people : reward : the greatest management principle in the world /
by: 351677 LeBoeuf, Michael
Published: (1986)

How to motivate people : reward : the greatest management principle in the world /
by: 351677 LeBoeuf, Michael
Published: (1985)

Eosinophilic fasciitis induced by nivolumab therapy managed without treatment interruption or systemic immunosuppression
by: Ai-Tram N. Bui, BA, et al.
Published: (2020-08-01)

Hypersensitivity reactions following the Moderna messenger RNA-1273 vaccine
by: Alex Drohan, MD, et al.
Published: (2021-10-01)

Contact lens composition having increased oxygen permeability/
by: 459679 LeBoeuf, Albert R.
Published: (1981)

Profiling antibody epitopes induced by mRNA-1273 vaccination and boosters
by: Bethany Girard, et al.
Published: (2024-03-01)

Stability of beryllium-tungsten coatings under annealing up to 1273 K
by: R. Mateus, et al.
Published: (2024-03-01)

Myasthenia Gravis Presenting after Administration of the mRNA-1273 Vaccine
by: Yoji Hoshina, et al.
Published: (2022-07-01)

Immunogenicity and safety of heterologous mRNA-1273/MVC-COV1901 vaccination versus homologous mRNA1273 vaccination: A randomized, double-blind controlled study
by: Szu-Ting Huang, et al.
Published: (2023-11-01)

Bekerjalah lebih bijak bukan lebih kuat /
by: 191262 Collis, Jack, et al.
Published: (2003)

Caenorhabditis elegans Male Copulation Circuitry Incorporates Sex-Shared Defecation Components To Promote Intromission and Sperm Transfer
by: Brigitte LeBoeuf, et al.
Published: (2017-02-01)

Association between Itch and Cancer in 3836 Pediatric Pruritus Patients at a Tertiary Care Center
by: Micah Belzberg, et al.
Published: (2019-10-01)

Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccination
by: Wang-Huei Sheng, et al.
Published: (2022-04-01)

Analysis of the adverse events following the mRNA-1273 COVID-19 vaccine
by: Angel Shabu, et al.
Published: (2023-12-01)

Dyshidrotic bullous pemphigoid developing after Moderna mRNA-1273 vaccination
by: Tyng-Shiuan Hsieh, et al.
Published: (2023-01-01)

Antibody response to the messenger RNA‐1273 vaccine (Moderna) in liver transplant recipients
by: Antonio Cuadrado, et al.
Published: (2022-07-01)

Central retinal artery occlusion after Moderna mRNA-1273 vaccination
by: Sin Yu Chow, et al.
Published: (2022-11-01)

Pityriasis rubra pilaris potentially triggered by messenger RNA–1273 COVID vaccine
by: Etsubdenk M. Ajebo, MD, et al.
Published: (2022-05-01)

Acute Myocarditis Following Vaccination With the First Dose of the mRNA-1273 Vaccine
by: Abdulbaril Olagunju MD, et al.
Published: (2022-04-01)

Myocarditis following COVID‐19 mRNA (mRNA‐1273) vaccination
by: Suresh Babu Chellapandian, et al.
Published: (2022-04-01)

Pityriasis Rosea Shortly After mRNA-1273 COVID-19 Vaccination
by: Sun Hye Shin, et al.
Published: (2022-01-01)

New-onset chilblains in close temporal association to mRNA-1273 vaccination
by: Connie Kha, MD, et al.
Published: (2021-06-01)

Constructing germline research cohorts from the discarded reads of clinical tumor sequences
by: Alexander Gusev, et al.
Published: (2021-11-01)

Social administration of juvenile hormone to larvae increases body size and nutritional needs for pupation
by: Matteo A. Negroni, et al.
Published: (2023-12-01)